BRL-101

· Bioray Laboratories

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BRL-101, covering 2024-06-03 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia [Phase 1, Phase 2]